Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock surged 17.4% in premarket trading Tuesday after the clinical-stage biotech company reported positive preliminary data from its ETESIAN ...
The FDA has granted accelerated approval to Otsuka’s Voyxact for adults with primary IgAN at risk of disease progression, ...
Gan & Lee Pharmaceuticals begins GRADUAL-3 phase 3 study of first Chinese once-monthly GLP-1 RA for weight management: Beijing, China Monday, December 1, 2025, 18:00 Hrs [IST] Gan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback